Search Results 231-240 of 17324 for Teratogenic

1. Dendritic Cell Therapy After Cryosurgery in Combination With Pembrolizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Remove by Surgery - Mayo Clinic

   Any of the following because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn ...

2. Teriparatide (subcutaneous route) - Side effects & dosage - Mayo Clinic

   Teriparatide injection is used to treat osteoporosis in postmenopausal women who are at high risk for bone fracture. It reduces the risk of having bone and ...

3. A Phase I, Multi-Center, Open Label, Dose De-escalation and Expansion Study of Gemcitabine and Cisplatin with AG120 or Pemigatinib for Advanced Cholangiocarcinoma - Mayo Clinic

   Any of the following because this study involves investigational agents whose genotoxic, mutagenic, and teratogenic effects on the developing fetus and newborn ...

4. Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer - Mayo Clinic

   Any of the following because this study involves an agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn are unknown:.

5. A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma - Mayo Clinic

   Female patients who are pregnant are not eligible since fetal toxicities and teratogenic effects have been noted for several of the study drugs. A pregnancy ...

6. A Study to Evaluate Treatment of Established Chemotherapy-induced Neuropathy with Fingolimod - Mayo Clinic

   Any of the following because this study involves an agent that has known genotoxic, mutagenic and teratogenic effects: Pregnant persons;; Nursing persons ...

7. Pazopanib in Treating Patients with Metastatic Non-Clear Cell Kidney Cancer - Mayo Clinic

   Any of the following because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn ...

8. Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations - Mayo Clinic

   Female patients who are pregnant are ineligible since fetal toxicities and teratogenic effects have been noted for several of the study drugs. Lactating ...

9. INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) - Mayo Clinic

   For this reason and because other therapeutic agents used in this trial are known to be teratogenic, women of child-bearing potential (women who are not ...

10. A Study to Evaluate the Use of AR-42 (Histone Deacetylase Inhibitor) in the Treatment of Vestibular Schwannoma and Meningioma - Mayo Clinic

    ... teratogenic or abortifacient effects of AR-42 are not known; There is an unknown but potential risk for AEs in nursing infants secondary to treatment of the ...